Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1
Hisakata Yamada
 -- 2042 2023-04-19 01:47:54 |
2 format correction
Dean Liu
 -5 word(s) 2037 2023-04-19 03:06:47 |

Video Upload Options

We provide professional Video Production Services to translate complex research into visually appealing presentations. Would you like to try it?
No, upload directly Yes

Confirm

Are you sure to Delete?
Yes No
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Yamada, H. Peripheral Helper T Cells. Encyclopedia. Available online: https://encyclopedia.pub/entry/43216 (accessed on 18 November 2024).
Yamada H. Peripheral Helper T Cells. Encyclopedia. Available at: https://encyclopedia.pub/entry/43216. Accessed November 18, 2024.
Yamada, Hisakata. "Peripheral Helper T Cells" Encyclopedia, https://encyclopedia.pub/entry/43216 (accessed November 18, 2024).
Yamada, H. (2023, April 19). Peripheral Helper T Cells. In Encyclopedia. https://encyclopedia.pub/entry/43216
Yamada, Hisakata. "Peripheral Helper T Cells." Encyclopedia. Web. 19 April, 2023.
Peripheral Helper T Cells
Edit
This entry is adapted from the peer-reviewed paper 10.3390/ijms24086930

T-helper (Th)1 and Th17 cells are hypothesized to be pathogenic T cells in RA joints; however, lines of evidence do not fully support this hypothesis, showing polyfunctionality of the T cells. Recent progress in single-cell analysis technology has led to the discovery of a novel helper T-cell subset, peripheral helper T cells, and attracted attention to the previously unappreciated T-cell subsets, such as cytotoxic CD4 and CD8 T cells, in RA joints.

rheumatoid arthritis synovium Th1 Th17 Tph

1. A Novel CD4 T-Cell Subset Identified by Emerging High-Dimensional Single-Cell Analysis: Tph Cells

Although the “classical” flow cytometric analysis provides much information on molecular expression at single-cell levels, it depends on a hypothesis-based selection of fluorochrome antibodies for detection. However, recent progress in comprehensive high-dimensional analyses, such as mass cytometry (cytometry by time of flight, CyTOF) and single-cell RNA sequence (scRNAseq), has enabled examination of the expression of huge numbers of molecules or genes in each cell without prior information, which has drastically changed many fields of biological research, including RA. By using CyTOF, Rao et al. identified a novel CD4 T-cell population expressing high levels of programed death-1 (PD-1), an inhibitory receptor induced in T cells continually stimulated with T-cell receptors (TCRs), in the joints of RA patients [1]. An increase in the PD-1 expression of T cells in RA joints was demonstrated even before the discovery of Tph cells [2][3], but these studies did not recognize PD-1 as a marker of distinct CD4 T-cell populations. PD-1high CD4 T cells secrete IL-21 and C-X-C motif chemokine ligand (CXCL)13, a chemoattractant for B cells, and the ligand for C-X-C motif chemokine receptor (CXCR) 5, and are able to induce antibody production from B cells in vitro, similar to follicular helper T (Tfh) cells, which also express PD-1, as well as IL-21 and CXCL13, and help germinal center (GC) B cells in secondary lymphoid organs. However, the PD-1high CD4 T cells in RA joint do not express CXCR5, unlike Tfh cells. Hence, the PD-1high CXCR5- CD4 T cells are called peripheral helper T (Tph) cells. A cluster of T cells corresponding to Tph cells was also detected by scRNAseq analysis of RA synovial cells [4]. A more recently developed analysis detects two populations of Tph cells, namely PD-1high CXCL13low cells and CXCL13high cells in RA SF [5], but these are clonally related and, therefore, might reflect different activation statuses of the same subset of T cells.
There are also differences in the expression of transcription factors between Tfh and Tph cells. While Tfh cells express B-cell lymphoma 6 (BCL6) but not B-lymphocyte-induced maturation protein 1 (BLIMP1), the opposite trend is seen in Tph cells, although both express Maf (Table 1). In relation to this, Tfh and Tph cells are different in their ability to help naive B cells in vitro [6]. The development of human Tfh cells is experimentally induced by IL-12, Activin A, and transforming growth factor (TGF)-β [7]. As for Tph cells, Yoshitomi et al. have investigated their differentiation mechanism [8]. They first reported the presence of a T-cell population that spontaneously produces CXCL13 but is distinct from Tfh cell populations in RA joints, and named it ThCXCL13 [9], which is likely identical to the later discovered Tph. They subsequently found that in vitro culture of naive T cells in the presence of TCR stimulation and TGF-β induced CXCL13-producing CD4 T cells, and Sox4 was identified as the key transcription factor [8][10]. However, Sox4 failed to induce CXCL13 production in murine CD4 T cells in vitro [8], and there has been no study showing the presence of Tph cells in the joints of mouse models of RA. On the other hand, another group showed that in mice, CD4 T cells that had undergone lymphopenia-induced proliferation in vivo showed the PD-1+ CXCR5- phenotype. These T cells helped B cells to produce antibodies via IL-21 secretion, similar to human Tph cells [11]. This might be an alternative mechanism of human Tph cell differentiation, although its relevance needs to be addressed.
Table 1. Similarities and differences between Tfh and Tph cells.
  Tfh Tph
Similarity  
 Surface molecules PD-1high, ICOS+
 Cytokines IL-21, CXCL13
 Transcription factors Maf
Difference    
 Location Lymphoid organs Inflamed tissues
 Chemokine receptors CXCR5+, CCR2− CXCR5−, CCR2+
 Transcription factors BCL6 BLIMP1, Sox4
PD-1: programmed death-1, ICOS: inducible costimulator, IL-21: interleukin-21, CXCL13: C-X-C motif chemokine ligand 13, CXCR5: C-X-C motif chemokine receptor 5, CCR2: C-C motif ligand 2, BCL6: B-cell lymphoma 6, BLIMP1: B-lymphocyte-induced maturation protein 1.
As CXCL13 plays critical roles in GC formation, Tph cells are suggested to be involved in ectopic lymphoid neogenesis (ELN) in RA synovium. In line with this, Tph cells are abundant in the joints of ACPA-positive RA patients [1], and ACPA production by synovial B cells has been demonstrated [12]. However, it should be noted that ELNs are detected in the synovium of seronegative RA patients and those with even psoriatic arthritis [13]. Taken together with the notion that ACPA is detected before the onset of RA [14] and that the formation of ELNs correlates with local inflammation but not with autoantibody production [15], ELNs, as well as Tph cells, do not contribute critically to the production of ACPA in the serum of RA patients.
Aside from their helper functions for antibody production, Tph cells are equipped with proinflammatory functions. Rao et al. reported the expression of IFN-γ mRNA in sorted Tph cells [1]. Others reported, before the discovery of Tph, the presence of CD4 T cells that produce IL-21 and TNF-α in RA SF [16]. As described above, researchers also noticed a portion of CD4 T cells in RA joints that co-produce IFN-γ, IL-21, and GM-CSF [17]. Researchers extend this finding by showing that PD-1high CD4 T cells, namely Tph cells, in RA joints can produce TNF-α, IFN-γ, and GM-CSF, in addition to IL-21 and CXCL13, although there is a heterogeneity in the profile of cytokine production [18]. Intriguingly, blocking PD-1 signaling in Tph cells enhanced cytokine production and induced self-MHC-dependent spontaneous proliferation in vitro [18]. Taken together, this suggests a role for Tph cells as proinflammatory effectors in RA synovitis, not only helping B cells in local antibody production but also aiding ELN formation. It should be noted that Tph cells are not specifically detected in RA joints but are also present in other inflammatory tissues, such as the salivary grand of patients with Sjogren syndrome [19]. An expansion of Tph cells was also observed in the PB of patients with systemic lupus erythematosus [20]. These findings suggest the involvement of Tph cells in a variety of immune pathogenies and the presence of a common mechanism for their development. Thus, the discovery of Tph cells, which was achieved by using the latest technology, provides novel insights into the role of T cells in the joints of RA patients. It might also change the understanding of immune systems and treatment strategies for various immune-mediated disorders.

2. The Emerging Importance of Cytotoxic CD4 and CD8 T Cells in RA Joints

The high-dimensional single-cell analysis identified additional T-cell subsets in RA joints (Table 2). Fonseka et al. found an increase in the CD27-HLA-DR+ CD4 T cell population in the joints compared to the PB of RA patients [21]. Notably, these cells express higher levels of cytotoxicity-associated genes, including PRF1, GZMB, GZMA, and GNLY (genes for perforin-1, granzyme B, granzyme A, and granulysin, respectively) in addition to Th1-related genes, including IFNG and TBX21 [21]. Another group showed an increase in eomesodermin-expressing CD4 T cells in RASF [22]. They later showed, in flow cytometric analysis, an increased expression of cytotoxic molecules, including GZMB, PRF1, Hobit, NKG7, and GPR56 proteins, on CD4 T cells in SF of ACPA+ RA patients [5]. A scRNAseq analysis of SF cells identified a cytotoxic CD4 T-cell cluster expressing higher levels of NKG, GZMH, PRF1, and ZNF683 (Hobit) genes, while GPR56 was highly expressed in Tph cells. An earlier study on the histology of RA synovium showed the presence of perforin-expressing CD4 T cells [23]. Thus, CD4 T cells equipped with cytotoxic functions can be pathogenic in RA joints, although the roles of cytotoxic activity in the inflammatory process as well as the types of target cells, which likely express MHC class II, remain to be determined.
Table 2. CD4 T-cell clusters in RA joints reported by Argyriou et al. [5].
Cluster Name Differentially Expressed Genes Frequency in SF
Naive CD4 TCF7, CCR7, LEF1 − 1
CXCL13high Tph TNFRSF18, LAG3, CXCL13 +++
Central memory CD4 LTB, ZFP36L2, KLF2 ±
Effector CD4 CXCR3, TGFB1, KLRB1 ++
Treg FOXP3, IL2RA, TIGIT ++
Cytotoxic CD4 NKG7, GNLY, GZMH +
SESN3 CD4 TNFAIP3, SLC2A3, CDC14A ±
CXCL13low Tph PTPN13, PRDM1, NEAT1 +
Humanin CD4 MT-ATP6, MT-ND4, MTRNR2L12 − 1
EGR1 CD4 EGR1, IER2, NR4A1 − 1
Proliferating CD4 STMN1, MKI67, TUBA1B +
Activated CD4 CST3, HLA-DRA, HLA-DPA1 ±
1 Note that several clusters were detected only in PB.
CD8 T cells have largely been ignored in the field of RA research, mainly due to a lack of evidence supporting their involvement, in contrast to the case of CD4 T cells as described at the beginning. However, CD8 T cells not only exist in the joints of RA patients; their frequency among T cells is actually higher in the joints than PB [24]. Most CD8 T cells in the joint show an activated phonotype [25][26][27]. Here, the results of high-dimensional analysis of RA synovial cells further attract attention to CD8 T cells. Three CD8 T cell subsets with different expression patterns of cytotoxic molecules, GZMK, GZMB, and GNLY, were identified by scRNAseq [4]. On the other hand, CyTOF analysis identified four subsets of CD8 T cells based on the expression patterns of HLA-DR, PD-1, and PD-1-HLA-DR+ populations, including GZMK+GZMB+ effector T cells and GNLY+GZMB+ cytotoxic T lymphocytes (CTLs) (Table 3) [4]. Notably, the expression levels of IFN-γ of all these CD8 T-cell subsets were higher than those of CD4 T cells in RA joints. More recent analysis additionally demonstrated clonal expansion of the GZMK+GZMB+ CD8 T-cell population [24]. GZMK+GZMB+ CD8 T cells have lower cytotoxic potential than GZMK- GZMB+ CD8 T-cell populations. However, recombinant enzymatically active GZMK can activate synovial fibroblast to produce IL-6, C-C motif ligand (CCL)2 and reactive oxygen species in vitro [24]. Consistently, the culture supernatants of synovial CD8 T cells exerted similar effects on synovial fibroblasts, suggesting their potential as pathogenic T cells in RA. Interestingly, such CD8 T cells can be activated to produce IFN-γ in an antigen-independent manner, namely stimulation with IL-12 + IL-15 in vitro, and the profile of gene expression is similar to that of innate T cells, such as mucosal-associated invariant T (MAIT) and invariant natural killer T (iNKT) cells [24]. This remind researchers of the earlier observation in a mouse experiment that self-specific, innate-like CD8 T cells can be activated by IL-12 + IL-15 independently of TCR signaling [28], although the antigen specificity of CD8 T cells is unclear in the case of human RA. The high levels of IFN-γ production by CD8 T cells shed light on a role for IFN-γ as an important proinflammatory mediator of RA synovium, which was once thought not to be the case due to the emergence of Th17 cells. Notably, scRNAseq analysis of the synovial macrophages and fibroblasts of RA patients identified cell clusters with a signature of IFN stimulation in both cell lineages [4]. IFN-γ is also implicated in the generation of RANKL+ effector B cells in RA joints [29].
Table 3. CD8 T-cell clusters in RA joints reported by Zhang et al. [4] and Jonsson et al. [24].
scRNAseq Clusters CyTOF Clusters DEGs Abundance
GZMK+GZMB- PD-1+HLA-DR+/− GZMK, NKG7 Joint = PB
GZMK+GZMBlow (effector) PD-1−HLA-DR++ IFNG, HLA-DRB1 Joint > PB
GZMK−GZMBhigh (cytotoxic) PD-1−HLA-DR+ PRF1, GNLY Joint < PB
GZMK−GZMB− (naive) PD-1−HLA-DR− (?) 1 CCR7, IL7R Joint < PB
1 No information provided.
Regarding the PD-1+ CD8 T cells identified in the above study [4], researchers found them capable of producing IL-21 but CXCR5-negative, like Tph cells [30]. In line with this, an earlier study showed an association between the formation of ELN and the presence of CD40L-expressing CD8 T cells in the synovium [31]. In vivo depletion of human CD8 T cells in RA synovial explants that were implanted in severe combined immunodeficiency (SCID) mice resulted in disintegration of the GC structure in ELN [32]. Therefore, although less attention has been paid to them than CD4 T cells, CD8 T cells might also be a candidate for the pathogenic T cells in the joints of RA patients.

References

  1. Rao, D.A.; Gurish, M.F.; Marshall, J.L.; Slowikowski, K.; Fonseka, C.Y.; Liu, Y.; Donlin, L.T.; Henderson, L.A.; Wei, K.; Mizoguchi, F.; et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature 2017, 542, 110–114.
  2. Hatachi, S.; Iwai, Y.; Kawano, S.; Morinobu, S.; Kobayashi, M.; Koshiba, M.; Saura, R.; Kurosaka, M.; Honjo, T.; Kumagai, S. CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid. J. Rheumatol. 2003, 30, 1410–1419.
  3. Wan, B.; Nie, H.; Liu, A.; Feng, G.; He, D.; Xu, R.; Zhang, Q.; Dong, C.; Zhang, J.Z. Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis. J. Immunol. 2006, 177, 8844–8850.
  4. Zhang, F.; Wei, K.; Slowikowski, K.; Fonseka, C.Y.; Rao, D.A.; Kelly, S.; Goodman, S.M.; Tabechian, D.; Hughes, L.B.; Salomon-Escoto, K.; et al. Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry. Nat. Immunol. 2019, 20, 928–942.
  5. Argyriou, A.; Wadsworth, M.H., 2nd; Lendvai, A.; Christensen, S.M.; Hensvold, A.H.; Gerstner, C.; van Vollenhoven, A.; Kravarik, K.; Winkler, A.; Malmström, V.; et al. Single cell sequencing identifies clonally expanded synovial CD4+ TPH cells expressing GPR56 in rheumatoid arthritis. Nat. Commun. 2022, 13, 4046.
  6. Fortea-Gordo, P.; Nuño, L.; Villalba, A.; Peiteado, D.; Monjo, I.; Sánchez-Mateos, P.; Puig-Kröger, A.; Balsa, A.; Miranda-Carús, M.E. Two populations of circulating PD-1hiCD4 T cells with distinct B cell helping capacity are elevated in early rheumatoid arthritis. Rheumatology. 2019, 58, 1662–1673.
  7. Vinuesa, C.G.; Linterman, M.A.; Yu, D.; MacLennan, I.C. Follicular Helper T Cells. Ann. Rev. Immunol. 2016, 34, 335–368.
  8. Yoshitomi, H.; Kobayashi, S.; Miyagawa-Hayashino, A.; Okahata, A.; Doi, K.; Nishitani, K.; Murata, K.; Ito, H.; Tsuruyama, T.; Haga, H.; et al. Human Sox4 facilitates the development of CXCL13-producing helper T cells in inflammatory environments. Nat. Commun. 2018, 9, 3762.
  9. Kobayashi, S.; Murata, K.; Shibuya, H.; Morita, M.; Ishikawa, M.; Furu, M.; Ito, H.; Ito, J.; Matsuda, S.; Watanabe, T.; et al. A distinct human CD4+ T cell subset that secretes CXCL13 in rheumatoid synovium: CXCL13-producing CD4+ T cells in RA synovium. Arthritis Rheum. 2013, 65, 3063–3072.
  10. Kobayashi, S.; Watanabe, T.; Suzuki, R.; Furu, M.; Ito, H.; Ito, J.; Matsuda, S.; Yoshitomi, H. TGF-β induces the differentiation of human CXCL13-producing CD4(+) T cells. Eur. J. Immunol. 2016, 46, 360–371.
  11. Eri, T.; Kawahata, K.; Kanzaki, T.; Imamura, M.; Michishita, K.; Akahira, L.; Bannai, E.; Yoshikawa, N.; Kimura, Y.; Satoh, T.; et al. Intestinal microbiota link lymphopenia to murine autoimmunity via PD-1+ CXCR5-/dim B-helper T induction. Sci. Rep. 2017, 7, 46037.
  12. Humby, F.; Bombardieri, M.; Manzo, A.; Kelly, S.; Blades, M.C.; Kirkham, B.; Spencer, J.; Pitzalis, C. Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med. 2009, 6, e1.
  13. Cañete, J.D.; Santiago, B.; Cantaert, T.; Sanmartí, R.; Palacin, A.; Celis, R.; Graell, E.; Gil-Torregrosa, B.; Baeten, D.; Pablos, J.L. Ectopic lymphoid neogenesis in psoriatic arthritis. Ann. Rheum. Dis. 2007, 66, 720–726.
  14. van de Sande, M.G.; de Hair, M.J.; van der Leij, C.; Klarenbeek, P.L.; Bos, W.H.; Smith, M.D.; Maas, M.; de Vries, N.; van Schaardenburg, D.; Dijkmans, B.A.; et al. Different stages of rheumatoid arthritis: Features of the synovium in the preclinical phase. Ann. Rheum. Dis. 2011, 70, 772–777.
  15. Cantaert, T.; Kolln, J.; Timmer, T.; van der Pouw Kraan, T.C.; Vandooren, B.; Thurlings, R.M.; Cañete, J.D.; Catrina, A.I.; Out, T.; Verweij, C.L.; et al. B lymphocyte autoimmunity in rheumatoid synovitis is independent of ectopic lymphoid neogenesis. J. Immunol. 2008, 181, 785–794.
  16. Lebre, M.C.; Vieira, P.L.; Tang, M.W.; Aarrass, S.; Helder, B.; Newsom-Davis, T.; Tak, P.P.; Screaton, G.R. Synovial IL-21/TNF-producing CD4+ T cells induce joint destruction in rheumatoid arthritis by inducing matrix metalloproteinase production by fibroblast-like synoviocytes. J. Leukoc. Biol. 2017, 101, 775–783.
  17. Yamada, H.; Haraguchi, A.; Sakuraba, K.; Okazaki, K.; Fukushi, J.-I.; Mizu-Uchi, H.; Akasaki, Y.; Esaki, Y.; Kamura, S.; Fujimura, K.; et al. Th1 is the predominant helper T cell subset that produces GM-CSF in the joint of rheumatoid arthritis. RMD Open. 2017, 3, e000487.
  18. Sakuragi, T.; Yamada, H.; Haraguchi, A.; Kai, K.; Fukushi, J.-I.; Ikemura, S.; Akasaki, Y.; Fujiwara, T.; Tsushima, H.; Tsutsui, T.; et al. Autoreactivity of Peripheral Helper T Cells in the Joints of Rheumatoid Arthritis. J. Immunol. 2021, 206, 2045–2051.
  19. Pontarini, E.; Murray-Brown, W.J.; Croia, C.; Lucchesi, D.; Conway, J.; Rivellese, F.; Fossati-Jimack, L.; Astorri, E.; Prediletto, E.; Corsiero, E.; et al. Unique expansion of IL-21+ Tfh and Tph cells under control of ICOS identifies Sjögren’s syndrome with ectopic germinal centres and MALT lymphoma. Ann. Rheum. Dis. 2020, 79, 1588–1599.
  20. Bocharnikov, A.V.; Keegan, J.; Wacleche, V.S.; Cao, Y.; Fonseka, C.Y.; Wang, G.; Muise, E.; Zhang, K.X.; Arazi, A.; Keras, G.; et al. PD-1hiCXCR5- T peripheral helper cells promote B cell responses in lupus via MAF and IL-21. JCI Insight. 2019, 4, e130062.
  21. Fonseka, C.Y.; Rao, D.A.; Teslovich, N.C.; Korsunsky, I.; Hannes, S.K.; Slowikowski, K.; Gurish, M.F.; Donlin, L.T.; Lederer, J.A.; Weinblatt, M.E.; et al. Mixed-effects association of single cells identifies an expanded effector CD4+ T cell subset in rheumatoid arthritis. Sci. Transl. Med. 2018, 10, eaaq0305.
  22. Chemin, K.; Ramsköld, D.; Diaz-Gallo, L.M.; Herrath, J.; Houtman, M.; Tandre, K.; Rönnblom, L.; Catrina, A.; Malmström, V. EOMES-positive CD4+ T cells are increased in PTPN22 (1858T) risk allele carriers. Eur. J. Immunol. 2018, 48, 655–669.
  23. Namekawa, T.; Wagner, U.G.; Goronzy, J.J.; Weyand, C.M. Functional subsets of CD4 T cells in rheumatoid synovitis. Arthritis Rheum. 1998, 41, 2108–2116.
  24. Jonsson, A.H.; Zhang, F.; Dunlap, G.; Gomez-Rivas, E.; Watts, G.F.M.; Faust, H.J.; Rupani, K.V.; Mears, J.R.; Meednu, N.; Wang, R.; et al. Granzyme K+ CD8 T cells form a core population in inflamed human tissue. Sci. Transl. Med. 2022, 14, eabo0686.
  25. Yamada, H.; Nakashima, Y.; Okazaki, K.; Mawatari, T.; Fukushi, J.; Oyamada, A.; Fujimura, K.; Iwamoto, Y.; Yoshikai, Y. Preferential accumulation of activated Th1 cells not only in rheumatoid arthritis but also in osteoarthritis joints. J. Rheumatol. 2011, 38, 1569–1575.
  26. Takeshita, M.; Suzuki, K.; Kondo, Y.; Morita, R.; Okuzono, Y.; Koga, K.; Kassai, Y.; Gamo, K.; Takiguchi, M.; Kurisu, R.; et al. Multi-dimensional analysis identified rheumatoid arthritis-driving pathway in human T cell. Ann. Rheum. Dis. 2019, 78, 1346–1356.
  27. Carvalheiro, H.; Duarte, C.; Silva-Cardoso, S.; da Silva, J.A.P.; Souto-Carneiro, M.M. CD8+ T cell profiles in patients with rheumatoid arthritis and their relationship to disease activity. Arthritis Rheumatol. 2015, 67, 363–371.
  28. Yamada, H.; Nakamura, T.; Matsuzaki, G.; Iwamoto, Y.; Nomoto, K. TCR-independent activation of extrathymically developed, self antigen-specific T cells by IL-2/IL-15. J. Immunol. 2000, 164, 1746–1752.
  29. Nakayama, T.; Yoshimura, M.; Higashioka, K.; Miyawaki, K.; Ota, Y.; Ayano, M.; Kimoto, Y.; Mitoma, H.; Ono, N.; Arinobu, Y.; et al. Type 1 helper T cells generate CXCL9/10-producing T-bet+ effector B cells potentially involved in the pathogenesis of rheumatoid arthritis. Cell Immunol. 2021, 360, 104263.
  30. Higashioka, K.; Yoshimura, M.; Sakuragi, T.; Ayano, M.; Kimoto, Y.; Mitoma, H.; Ono, N.; Arinobu, Y.; Kikukawa, M.; Yamada, H.; et al. Human PD-1hiCD8+ T cells are a cellular source of IL-21 in rheumatoid arthritis. Front. Immunol. 2021, 12, 654623.
  31. Wagner, U.G.; Kurtin, P.J.; Wahner, A.; Brackertz, M.; Berry, D.J.; Goronzy, J.J.; Weyand, C.M. The Role of CD8+ CD40L+ T cells in the formation of germinal centers in rheumatoid synovitis. J. Immunol. 1998, 161, 6390–6397.
  32. Kang, Y.M.; Zhang, X.; Wagner, U.G.; Yang, H.; Beckenbaugh, R.D.; Kurtin, P.J.; Goronzy, J.J.; Weyand, C.M. CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis. J. Exp. Med. 2002, 195, 1325–1336.
More
© Text is available under the terms and conditions of the Creative Commons Attribution (CC BY) license; additional terms may apply. By using this site, you agree to the Terms and Conditions and Privacy Policy.
Upload a video for this entry
Information
Subjects: Immunology
Contributor MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register :
Hisakata Yamada
View Times: 313
Revisions: 2 times (View History)
Update Date: 24 Apr 2023
Table of Contents
    1000/1000
    Hot Most Recent
    ScholarVision Creations
    Feedback